Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Charles River to close Maryland CDMO site, lay off 20 staffers
“After a thoughtful review, we determined that our cell therapy facility in Hanover, MD, is not a strategic fit,” a spokesperson told Fierce.
Will Maddox
Feb 3, 2026 12:20pm
CRO Sygnature Discovery plans to send 60 UK staffers packing
Jan 30, 2026 5:00pm
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Kardigan CEO knits trials, digital health into cardio strategy
Jan 28, 2026 10:00am
Ex-CytoDyn CEO sentenced as alleged co-conspirator wins new trial
Jan 26, 2026 11:00am
Worldwide Clinical Trials adds Catalyst to global CRO mixture
Jan 20, 2026 2:54pm
